Skip to main content
. 2016 Feb 17;18(4):360–366. doi: 10.1016/j.hpb.2015.11.003

Table 1.

Demographics and perioperative variables of pancreatectomy subjects

Variable Subjects (N = 227)
Age, years (range) 62 (22–88)
BMI, kg/m2 (range) 27 (16–56)
Gender, N (%)
Male 107 (47)
Female 120 (53)
Resection Type, N (%)
Pancreaticoduodenectomy 159 (70)
Distal pancreatectomy 63 (28)
Enucleation 5 (2)
Pathology, N (%)
Benign
IPMN 35 (15)
Serous cystadenoma 10 (4)
Mucinous cystadenoma 7 (3)
GIST 2 (1)
Others 18 (8)
Malignant
PDAC 100 (44)
Ampullary adenocarcinoma 28 (12)
Neuroendocrine carcinoma 13 (6)
Cholangiocarcinoma 9 (4)
Duodenal adenocarcinoma 4 (2)
Metastasis 1 (0.4)
Tumor location, N (%)
Head 150 (66)
Body 35 (15)
Tail 27 (12)
Unknown 15 (7)
Tumor size, cm (range) 3.0 (0.2–17.0)
Pancreatitis on pathology, N (%)
Yes 57 (25)
No 153 (67)
Unknown 17 (7)
Chemotherapy, N (%)
Neoadjuvant 18 (8)
Adjuvant 109 (48)
Radiation, N (%)
Neoadjuvant 17 (8)
Adjuvant 80 (35)

BMI, body mass index; GIST, gastrointestinal stromal tumor; IPMN, intraductal papillary mucinous neoplasm; PDAC, pancreatic ductal adenocarcinoma.